Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label attachment file name title
tabling member	label

Search

967805

registered interest
date	04/09/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential effect of the UK leaving the EU on patient access to short-shelf life medicines.
tabling member constituency	Cambridge
tabling member printed	Daniel Zeichner
uin	170342
answer	answer is ministerial correction date of answer 12/09/2018 answer text <p>The Government has made significant progress in negotiations with the European Union and remains confident the United Kingdom will leave with a good deal for both sides. This deal will include ensuring patients in the UK have access to appropriate, safe, and cost effective medicines, including short shelf-life medicines.</p><p> </p><p>However, as a responsible Government, we continue to prepare proportionately for all scenarios, including the unlikely outcome that we leave the EU without any deal in March 2019. Therefore on 23 August 2018, the Department wrote to a number of pharmaceutical companies that supply medicines for National Health Service patients from, or via, the EU/European Economic Area (EEA), asking them to ensure that they have a minimum of six weeks additional supply in the UK, over and above their business as usual operational buffer stocks by 29 March 2019.</p><p> </p><p>For certain medicines with short shelf lives, which cannot be reasonably stockpiled, we are specifically asking that where these products are imported to the UK from the EU/EEA via road haulage and roll-on, roll-off sea, road and rail routes, suppliers ensure in advance plans to air freight these medicines to the UK. This will ensure that UK patients have the same access to these medicines as they currently do in unlikely event of the UK leaving the EU without a deal.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 12/09/2018 16:26:05 answering member 4067 label Biography information for Steve Brine
tabling member	4382 label Biography information for Daniel Zeichner

967806

registered interest
date	04/09/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Pharmaceutical Price Regulation Scheme
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what estimate his Department has made of the total value of rebates to be paid under the Pharmaceutical Price Regulation Scheme 2014.
tabling member constituency	Cambridge
tabling member printed	Daniel Zeichner
uin	170343
answer	answer is ministerial correction date of answer 12/09/2018 answer text <p>The Department has received £2,328 million from members of the Pharmaceutical Price Regulation Scheme (PPRS), as of Q1 2018, in respect of PPRS payments made under the 2014 scheme. The estimated United Kingdom income from PPRS payments in 2018/19 is £470 million. Published aggregate information on sales reports and payments made under the scheme on a quarterly basis can be found on the Government’s website at the following link:</p><p> </p><p><a href="https://www.gov.uk/government/collections/pprs-quarterly-net-sales-and-payment-information" target="_blank">https://www.gov.uk/government/collections/pprs-quarterly-net-sales-and-payment-information</a></p><p> </p><p>The Department administers the scheme on behalf of all UK nations and PPRS payments that companies make under the scheme in respect of the UK are allocated to each of the four countries on an agreed basis each year. The Department ensures that all the income it receives from PPRS payments in England is reinvested in the National Health Service for patients’ benefit. The Department includes the expected PPRS payments in setting the NHS England allocations in advance of each year. NHS England is responsible for allocating the overall budget between clinical commissioning groups, specialised commissioning etc.</p><p> </p><p>Following normal Government accounting rules, there is no separately identified or ring-fenced funding stream associated with the PPRS payment. The Government is committed to improving access to clinically and cost-effective medicines including innovative new medicines and to optimise patient outcomes from these medicines.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 170344 170345 question first answered 12/09/2018 16:32:57 answering member 4067 label Biography information for Steve Brine
tabling member	4382 label Biography information for Daniel Zeichner

967807

registered interest
date	04/09/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Pharmaceutical Price Regulation Scheme
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what information his Department holds on how money raised from rebates paid under the Pharmaceutical Price Regulation Scheme 2014 has been used; and if he will make a statement.
tabling member constituency	Cambridge
tabling member printed	Daniel Zeichner
uin	170344
answer	answer is ministerial correction date of answer 12/09/2018 answer text <p>The Department has received £2,328 million from members of the Pharmaceutical Price Regulation Scheme (PPRS), as of Q1 2018, in respect of PPRS payments made under the 2014 scheme. The estimated United Kingdom income from PPRS payments in 2018/19 is £470 million. Published aggregate information on sales reports and payments made under the scheme on a quarterly basis can be found on the Government’s website at the following link:</p><p> </p><p><a href="https://www.gov.uk/government/collections/pprs-quarterly-net-sales-and-payment-information" target="_blank">https://www.gov.uk/government/collections/pprs-quarterly-net-sales-and-payment-information</a></p><p> </p><p>The Department administers the scheme on behalf of all UK nations and PPRS payments that companies make under the scheme in respect of the UK are allocated to each of the four countries on an agreed basis each year. The Department ensures that all the income it receives from PPRS payments in England is reinvested in the National Health Service for patients’ benefit. The Department includes the expected PPRS payments in setting the NHS England allocations in advance of each year. NHS England is responsible for allocating the overall budget between clinical commissioning groups, specialised commissioning etc.</p><p> </p><p>Following normal Government accounting rules, there is no separately identified or ring-fenced funding stream associated with the PPRS payment. The Government is committed to improving access to clinically and cost-effective medicines including innovative new medicines and to optimise patient outcomes from these medicines.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 170343 170345 question first answered 12/09/2018 16:32:58 answering member 4067 label Biography information for Steve Brine
tabling member	4382 label Biography information for Daniel Zeichner

967808

registered interest
date	04/09/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Pharmaceutical Price Regulation Scheme
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, for what reasons rebates paid by manufacturers under the Pharmaceutical Price Regulation Scheme 2014 are not ring-fenced for the use of medicines; and if he will make a statement.
tabling member constituency	Cambridge
tabling member printed	Daniel Zeichner
uin	170345
answer	answer is ministerial correction date of answer 12/09/2018 answer text <p>The Department has received £2,328 million from members of the Pharmaceutical Price Regulation Scheme (PPRS), as of Q1 2018, in respect of PPRS payments made under the 2014 scheme. The estimated United Kingdom income from PPRS payments in 2018/19 is £470 million. Published aggregate information on sales reports and payments made under the scheme on a quarterly basis can be found on the Government’s website at the following link:</p><p> </p><p><a href="https://www.gov.uk/government/collections/pprs-quarterly-net-sales-and-payment-information" target="_blank">https://www.gov.uk/government/collections/pprs-quarterly-net-sales-and-payment-information</a></p><p> </p><p>The Department administers the scheme on behalf of all UK nations and PPRS payments that companies make under the scheme in respect of the UK are allocated to each of the four countries on an agreed basis each year. The Department ensures that all the income it receives from PPRS payments in England is reinvested in the National Health Service for patients’ benefit. The Department includes the expected PPRS payments in setting the NHS England allocations in advance of each year. NHS England is responsible for allocating the overall budget between clinical commissioning groups, specialised commissioning etc.</p><p> </p><p>Following normal Government accounting rules, there is no separately identified or ring-fenced funding stream associated with the PPRS payment. The Government is committed to improving access to clinically and cost-effective medicines including innovative new medicines and to optimise patient outcomes from these medicines.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 170343 170344 question first answered 12/09/2018 16:32:58 answering member 4067 label Biography information for Steve Brine
tabling member	4382 label Biography information for Daniel Zeichner

967819

registered interest
date	04/09/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	European Food Safety Authority
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what plans he has to maintain the responsibilities and functions of the European Food Safety Authority when the UK leaves the EU (a) with and (b) without a deal.
tabling member constituency	Workington
tabling member printed	Sue Hayman
uin	170350
answer	answer is ministerial correction date of answer 10/09/2018 answer text <p>We firmly believe it is in the interests of both the European Union and the United Kingdom to strike a deal. That remains the goal on both sides and we are confident that this will be achieved. As is the job of a responsible Government, we have already carried out very significant no deal preparations and will be setting out further details on food safety shortly so that business and citizens have time to prepare. The UK’s priority is to maintain our high standards of food and feed safety.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 10/09/2018 17:07:09 answering member 4067 label Biography information for Steve Brine
tabling member	4395 label Biography information for Baroness Hayman of Ullock

967820

registered interest
date	04/09/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Food: EU Law
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, with reference to the White Paper, The future relationship between the United Kingdom and the European Union, published in July 2018, whether he has plans to replicate the provisions of Regulation (EC) No 178/2002 in the common rulebook.
tabling member constituency	Workington
tabling member printed	Sue Hayman
uin	170351
answer	answer is ministerial correction date of answer 12/09/2018 answer text <p>The content of the common rule book will form part of ongoing discussions between Her Majesty’s Government and the T50 taskforce, to ensure that the content of the common rule book account for a robust and safe food system between the United Kingdom and European Union. The rule book will only include those rules necessary to provide for frictionless trade at the border. The specific regulations which are considered for the rulebook will form a part of these ongoing discussions.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 12/09/2018 15:55:57 answering member 4067 label Biography information for Steve Brine
tabling member	4395 label Biography information for Baroness Hayman of Ullock

967836

registered interest
date	04/09/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Breast Cancer
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what the rate of (a) age-standardised premature mortality from breast cancer and (b) uptake of screening for that cancer was in each clinical commissioning group area in the last period for which figures are available.
tabling member constituency	Lincoln
tabling member printed	Karen Lee
uin	170447
answer	answer is ministerial correction date of answer 12/09/2018 answer text <p>The Office for National Statistics has published data on the number of deaths and age-standardised mortality rates where breast cancer (ICD-10 code: C50) was the underlying cause of death, in those aged 0 to 74 years, by sex, England and Wales, 2012 to 2016 at the following link:</p><p> </p><p><a href="https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/causesofdeath/adhocs/008966deathsandagestandardisedmortalityrateswherebreastcancerwastheunderlyingcauseaged0to74yearsbysexenglandandwales2012to2016" target="_blank">https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/causesofdeath/adhocs/008966deathsandagestandardisedmortalityrateswherebreastcancerwastheunderlyingcauseaged0to74yearsbysexenglandandwales2012to2016</a></p><p> </p><p>Data on the uptake of breast cancer screening are not available by clinical commissioning group level. Figures for uptake for screening during 2016/17 (screening year of 1 April 2016 to 31 March 2017) are published by NHS Digital. The information for each area is provided at a breast screening service level is attached.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 12/09/2018 16:29:52 answering member 4067 label Biography information for Steve Brine attachment 1 file name PQ170447 document format.xlsx title PQ170447 attached document
tabling member	4664 label Biography information for Karen Lee

967840

registered interest
date	04/09/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Asbestos: Drinking Water
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what the latest advice is that he has received from Public Health England on the risks of ingesting asbestos from drinking water which has been pumped through asbestos pipes.
tabling member constituency	South West Bedfordshire
tabling member printed	Andrew Selous
uin	170282
answer	answer is ministerial correction date of answer 10/09/2018 answer text <p>Public Health England’s advice is in line with that of the World Health Organization Guidelines on drinking water quality that there is no convincing or consistent evidence that ingested asbestos from asbestos cement drinking water pipes provides a risk to public health.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 10/09/2018 17:08:34 answering member 4067 label Biography information for Steve Brine
tabling member	1453 label Biography information for Andrew Selous

967841

registered interest
date	04/09/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Wirral Clinical Commissioning Group
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what recent assessment he has made of the effectiveness of the leadership at Wirral Clinical Commissioning Group.
tabling member constituency	Birkenhead
tabling member printed	Frank Field
uin	170269
answer	answer is ministerial correction date of answer 12/09/2018 answer text <p>The most recent formal assessment of the effectiveness of the leadership at NHS Wirral Clinical Commissioning Group (CCG) was as part of the 2017/18 CCG Improvement and Assessment Framework, the annual national assessment process for CCGs.</p><p> </p><p>In this assessment Wirral CCG received a headline rating of ‘Requires Improvement’. There are four categories: ‘Outstanding’, ‘Good’, ‘Requires Improvement’ and ‘Inadequate’.</p><p> </p><p>Within this, an annual assessment of the quality of leadership is made, and published on the MyNHS section of the NHS Choices website along with all the other indicators.</p><p> </p><p>The quality of leadership rating is on a scale from ‘Green Star’, ‘Green’, ‘Amber’ or ‘Red’. NHS Wirral CCG was rated as ‘Amber’ within this assessment for 2017/18.</p><p> </p><p>The link to the published ratings is available at the following link:</p><p> </p><p><a href="https://www.nhs.uk/service-search/Performance/Search" target="_blank">https://www.nhs.uk/service-search/Performance/Search</a></p> answering member constituency Winchester answering member printed Steve Brine question first answered 12/09/2018 16:24:50 answering member 4067 label Biography information for Steve Brine
tabling member	478 label Biography information for Lord Field of Birkenhead

967878

registered interest
date	04/09/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Drugs: Misuse
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what estimate he has made of the annual cost to the NHS of drug addiction; and if his Department will publish an estimate of those annual costs in each financial year since 2010-11.
tabling member constituency	Leicester South
tabling member printed	Jonathan Ashworth
uin	170319
answer	answer is ministerial correction date of answer 10/09/2018 answer text <p>The costs of drug addiction are difficult to estimate due to the range of impacts. The latest estimates by the Home Office, in the 2017 Drug Strategy, suggest that in the United Kingdom society bears an estimated £10.7 billion of drug-related costs in terms of crime, healthcare and law enforcement. There are no plans to publish estimates of the annual costs to the National Health Service of drug addiction.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 10/09/2018 16:57:26 answering member 4067 label Biography information for Steve Brine
tabling member	4244 label Biography information for Jonathan Ashworth